218162-49-3Relevant articles and documents
An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors
McKenna, Jeffrey M.,Halley, Frank,Souness, John E.,McLay, Iain M.,Pickett, Stephen D.,Collis, Alan J.,Page, Kenneth,Ahmed, Imtiaz
, p. 2173 - 2184 (2007/10/03)
Previously we reported the identification of RPR200765A, a potent orally bioavailable pyridine - imidazole inhibitor of p38 mitogen-activated protein (MAP) kinase which suppressed paw swelling and joint pathology in streptococcal cell wall-induced arthrit